crypto token vs cryptocurrency searches

This week, the Shenzhen Stock Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, and the Shenzhen Stock Exchange released regulatory trends: 1. Regulatory trends of listed companies (December 6-December 12, 2024) From December 6 to December 12, the Exchange took disciplinary action against one violation, involving information disclosure and standardized operation violations; Supervision letters were issued for 9 violations, 3 related to information disclosure and standardized operation violations, and 6 related to securities trading violations. This week, 18 inquiry letters and 5 other letters were sent out. II. Market Trading Supervision Dynamics (December 9-December 13, 2024) From December 9 to December 13, the Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, involving abnormal trading situations such as intraday bidding, false declaration, etc. Focus on monitoring "*ST Tongzhou" with abnormal stock price fluctuation recently; A total of 9 major events of listed companies were verified, and 3 clues of suspected illegal cases were reported to the CSRC. (Issued by Shenzhen Stock Exchange)The Stoxx Europe 600 index fell to an intraday low of 0.5%.The European Central Bank announced the change in the data release of the Emergency Anti-epidemic Bond Purchase Program (PEPP). The European Central Bank said that on December 5, 2024, the Management Committee approved the change in the data release of the monetary policy portfolio under the Emergency Anti-epidemic Bond Purchase Program (PEPP), because with the time to suspend reinvestment under the Emergency Anti-epidemic Bond Purchase Program (PEPP) at the end of 2024 approaching, the euro system will not be in the asset purchase program or emergency anti-epidemic for the first time since 2014. Predictable changes will ensure that the level of transparency provided by future published data remains appropriate. It is reported that the data of the Emergency Anti-epidemic Bond Purchase Program (PEPP) will be released once a month instead of once every two months to match the equivalent asset purchase program data series, and the series of historical monthly data since the launch of the program will be released. The release systems of emergency anti-epidemic bond purchase plan (PEPP) and asset purchase plan will be further aligned, including the release of retrospective and prospective redemption data of PEPP. The change will be implemented from January 8, 2025.

Brazilian President's Office: Brazilian President Lula recovered well after surgery, and his speech and diet were normal.Guangyunda: It is planned to raise no more than 448.9 million yuan from Junguang Investment. Guangyunda announced that the type of shares to be issued by the company to a specific target is domestic listed RMB ordinary shares (A shares) with a par value of RMB 1.00 per share. The object of issue is Shenzhen Junguang Investment Holding Co., Ltd., and the issue price is determined to be 7.74 yuan/share. The number of shares issued this time does not exceed 58 million shares (inclusive), which does not exceed 30% of the total share capital of the company before this issuance. The total amount of funds raised by the proposed stock issue to a specific target does not exceed RMB 448.92 million (inclusive), and the net amount of funds raised after deducting the issuance expenses is intended to be used to supplement the working capital. This proposal still needs to be submitted to the company's shareholders' meeting for consideration.Ukraine National Natural Gas Transportation Company: On December 14th, the Russian natural gas passing through Sujia border crossing point was 42.39 million cubic meters, and on December 13th, it was 42.33 million cubic meters.

Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.This week, the Shenzhen Stock Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, and the Shenzhen Stock Exchange released regulatory trends: 1. Regulatory trends of listed companies (December 6-December 12, 2024) From December 6 to December 12, the Exchange took disciplinary action against one violation, involving information disclosure and standardized operation violations; Supervision letters were issued for 9 violations, 3 related to information disclosure and standardized operation violations, and 6 related to securities trading violations. This week, 18 inquiry letters and 5 other letters were sent out. II. Market Trading Supervision Dynamics (December 9-December 13, 2024) From December 9 to December 13, the Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, involving abnormal trading situations such as intraday bidding, false declaration, etc. Focus on monitoring "*ST Tongzhou" with abnormal stock price fluctuation recently; A total of 9 major events of listed companies were verified, and 3 clues of suspected illegal cases were reported to the CSRC. (Issued by Shenzhen Stock Exchange)